Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DBTX

Decibel Therapeutics (DBTX) Stock Price, News & Analysis

Decibel Therapeutics logo

About Decibel Therapeutics Stock (NASDAQ:DBTX)

Advanced Chart

Key Stats

Today's Range
$4.90
$5.11
50-Day Range
$4.91
$5.23
52-Week Range
$1.61
$5.40
Volume
1.26 million shs
Average Volume
122,002 shs
Market Capitalization
$123.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DBTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Decibel Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

DBTX Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
The Best Noise-Cancelling Headphones
Decibel Therapeutics' CVR Appears Around Fair Value
See More Headlines

DBTX Stock Analysis - Frequently Asked Questions

Decibel Therapeutics, Inc. (NASDAQ:DBTX) released its earnings results on Wednesday, November, 10th. The company reported ($0.66) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.43) by $0.23.

Decibel Therapeutics (DBTX) raised $100 million in an initial public offering (IPO) on Friday, February 12th 2021. The company issued 5,900,000 shares at $16.00-$18.00 per share. Citigroup, BMO Capital Markets, SVB Leerink and Barclays acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Decibel Therapeutics investors own include Predictive Oncology (POAI), Ford Motor (F), Zomedica (ZOM), Wells Fargo & Company (WFC), Bank of America (BAC), JPMorgan Chase & Co. (JPM) and Abbott Laboratories (ABT).

Company Calendar

Last Earnings
11/10/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:DBTX
CIK
1656536
Fax
N/A
Employees
68
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.53)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63.01 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-84.03%
Return on Assets
-53.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.03
Quick Ratio
3.03

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.28 per share
Price / Book
1.50

Miscellaneous

Outstanding Shares
25,130,000
Free Float
16,182,000
Market Cap
$123.39 million
Optionable
Not Optionable
Beta
-0.43
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:DBTX) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners